Stocktoria

ENANTA PHARMACEUTICALS INC ENTA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-03-21 · LEI

ENANTA PHARMACEUTICALS INC statistics & valuation

Market cap$407.1M
P / S6.2×
P / B6.3×
Net margin-125.4%
Return on equity-126.5%
FCF margin-49.2%
Return on capital-36.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
24.50% 17.20% 34.80% 22.60% -29.50% -81.40% -141.30% -169.00% -171.60% -125.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
34.90% 23.90% 42.70% 17.90% -34.00% -112.90% -143.70% -173.20% -179.90% -130.70% 2016201720182019202020212022202320242025
Return on equity (%)
8.00% 5.90% 18.30% 10.00% -7.90% -19.80% -37.90% -61.70% -90.10% -126.50% 2016201720182019202020212022202320242025
Shares outstanding
19.2M 19.4M 20.6M 21.0M 20.1M 20.2M 20.8M 21.1M 21.4M 21.4M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
7.70% 5.40% 17.40% 9.50% -7.40% -18.00% -32.40% -28.90% -30.80% -29.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
35.20% 48.80% 12.70% 32.20% 4.60% -72.90% -100.90% -141.70% -143.00% -49.20% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$1.13 $0.91 $3.48 $2.21 -$1.81 -$3.92 -$5.91 -$6.38 -$5.48 -$3.84 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ENANTA PHARMACEUTICALS INC trades at about 6.1× earnings — below its 10-year norm (10-year range 6.9×–54.6×, median 23.9×).

6.1× 54.6×

Shaded band = 10-year range (6.9×–54.6×); dot = today's 6.1×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-130.7%-179.9%-173.2%-143.7%-112.9%-34.0%17.9%42.7%23.9%34.9%
Net margin-125.4%-171.6%-169.0%-141.3%-81.4%-29.5%22.6%34.8%17.2%24.5%
FCF margin-49.2%-143.0%-141.7%-100.9%-72.9%4.6%32.2%12.7%48.8%35.2%
Return on assets-29.2%-30.8%-28.9%-32.4%-18.0%-7.4%9.5%17.4%5.4%7.7%
Return on equity-126.5%-90.1%-61.7%-37.9%-19.8%-7.9%10.0%18.3%5.9%8.0%
Current ratio4.215.216.7310.458.8218.0817.7723.7411.3329.43

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.